Top performing pharma funds

Henil Shah
/ Categories: Mutual Fund, MF Unlocked
Top performing pharma funds

Pharma or the healthcare sector has been an underperformer since April 2015. This underperformance extended for almost five years till March 2020 and from there, it recapitulated.

 

 

The above graph shows the 15-year journey of Nifty Pharma index. As we can see, it has started recovering from March 2020. Further, it is yet to reach its previous all-time high of 13,831. Once this level is breached, we might witness a further rally in the Nifty Pharma index. Therefore, even if you have missed the recent rally of 77 per cent, there are still a lot more opportunities left for you. In this article, we have listed the top three pharma mutual funds.

 

Fund Name

Trailing Returns (in per cent)

1 Year

3 Years

5 Years

10 Years

20 Years

Nippon India Pharma Fund

57.50

19.08

8.11

15.25

19.56

UTI Healthcare Fund

57.40

13.23

4.29

12.97

13.39

SBI Healthcare Opportunities Fund

57.01

10.17

2.92

15.36

13.43

 

 

Fund Name

Rolling Returns (in per cent)

1 Year

3 Years

5 Years

10 Years

Nippon India Pharma Fund

21.49

18.99

20.36

19.99

UTI Healthcare Fund

13.63

13.28

15.08

14.64

SBI Healthcare Opportunities Fund

14.56

13.24

16.17

15.42

Period: August 3, 2005 to August 3, 2020

 

 

From the above two tables, we can say that in terms of returns, Nippon India Pharma Fund tops the chart, followed by UTI Healthcare Fund and SBI Healthcare Opportunities Fund.

 

Fund Name

Risk Statistics

Sharpe Ratio

Sortino Ratio

Alpha

Beta

Standard Deviation

Nippon India Pharma Fund

0.63

1.42

7.57

0.85

20.87

UTI Healthcare Fund

0.36

0.76

1.91

0.89

21.75

SBI Healthcare Opportunities Fund

0.24

0.46

-0.58

0.88

21.74

 

 

Even in terms of risk and risk-adjusted returns metrics, Nippon India Pharma Fund came at the top, followed by UTI Healthcare Fund and SBI Healthcare Opportunities Fund.

 

One thing to note before investing in pharma funds is that, do not allocate these to any of your financial goals. They should be purely used for opportunity grabbing purposes. Further, if you are not well-versed with sectors that the sectoral fund invests in, then it is better to avoid such funds and invest in a diversified equity fund.

Rate this article:
3.8

Leave a comment

Add comment

DSIJ MINDSHARE

Mkt Commentary19-Mar, 2024

Mindshare19-Mar, 2024

Penny Stocks19-Mar, 2024

Multibaggers19-Mar, 2024

Multibaggers19-Mar, 2024

Knowledge

General18-Mar, 2024

General18-Mar, 2024

General17-Mar, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR